Levothyroxine dose following thyroidectomy is affected by more than just body weight

Laryngoscope

Volumn 122, Issue 4, 2012, Pages 834-838

  Baehr, Kara Meinke ^a   Lyden, Elizabeth ^b   Treude, Kelly ^a   Erickson, Judi ^a   Goldner, Whitney ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

levothyroxine; thyroid cancer; thyroid hormone replacement; thyroid nodules; Thyroidectomy

Indexed keywords

LEVOTHYROXINE;

ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE CALCULATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; PATIENT COMPLIANCE; POSTMENOPAUSE; POSTOPERATIVE CARE; PREMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; THYROID CANCER; THYROID NODULE; THYROIDECTOMY;

ADULT; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; THYROXINE; TREATMENT OUTCOME;

EID: 84858749815     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23186     Document Type: Article

References (19)

1. Lupoli GA, Fonderico F, Colarusso S, et al. Current management of differentiated thyroid carcinoma. Med Sci Monit 2005; 11: RA368-373.
2. McGriff NJ, Csako G, Gourgiotis L, et al. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 2002; 34: 554-564.
3. Jonklaas J, Sarlis NJ, Litofsky D, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 2006; 16: 1229-1242.
4. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214.
5. Gordon MB, Gordon MS,. Variations in adequate levothyroxine replacement therapy in patients with different causes of hypothyroidism. EndocrPract 1999; 5: 233-238.
6. Roti E, Minelli R, Gardini E, Braverman LE,. The use and misuse of thyroid hormone. EndocrRev 1993; 14: 401-423.
7. Burmeister LA, Goumaz MO, Mariash CN, Oppenheimer JH,. Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 1992; 75: 344-350.
8. Mandel SJ, Brent GA, Larsen PR,. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 1993; 119: 492-502.
9. Santini F, Pinchera A, Marsili A, et al. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab 2005; 90: 124-127.
10. Roos A, Linn-Rasker SP, van Domburg RT, et al. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med 2005; 165: 1714-1720.
11. Rosenbaum RL, Barzel US,. Levothyroxine replacement dose for primary hypothyroidism decreases with age. Ann Intern Med 1982; 96: 53-55.
12. Olubowale O, Chadwick DR,. Optimization of thyroxine replacement therapy after total or near-total thyroidectomy for benign thyroid disease. Br J Surg 2006; 93: 57-60.
13. Sukumar R, Agarwal A, Gupta S, et al. Prediction of LT4 replacement dose to achieve euthyroidism in subjects undergoing total thyroidectomy for benign thyroid disorders. World J Surg 2010; 34: 527-531.
14. John-Kalarickal J, Pearlman G, Carlson HE,. New medications which decrease levothyroxine absorption. Thyroid 2007; 17: 763-765.
15. Surks MI, Sievert R,. Drugs and thyroid function. N Engl J Med 1995; 333: 1688-1694.
16. Singh N, Singh PN, Hershman JM,. Effect of calcium carbonate on the absorption of levothyroxine. JAMA 2000; 283: 2822-2825.
17. Arafah BM,. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 2001; 344: 1743-1749.
18. Jonklaas J,. Sex and age differences in levothyroxine dosage requirement. Endocr Pract 2010; 16: 71-79.
19. Bartalena L, Martino E, Pacchiarotti A, et al. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrouspatients. J Clin Endocrinol Metab 1987; 64: 849-855.